Lemonade Inc. (LMND) PT Lowered to $26 at BofA Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts LMND Hot Sheet
Price: $44.77 +8.30%
Rating Summary:
3 Buy, 7 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Rating Summary:
3 Buy, 7 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 26 | New: 12
Join SI Premium – FREE
BofA Securities analyst Joshua Shanker lowered the price target on Lemonade Inc. (NYSE: LMND) to $26.00 (from $27.00) while maintaining a Underperform rating.
You May Also Be Interested In
- Lemonade renters insurance now available in all 50 states
- Viridian Therapeutic (VRDN) PT Raised to $43 at Stifel
- United Therapeutics Corp. (UTHR) PT Raised to $720 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
